SureBeam Corporation (Nasdaq: SURE) -- innovator of the nation's first electronic pasteurization system for food -- announced today that it has been awarded a U.S. patent for a major technological advancement that allows a single electron beam machine to process continuously and simultaneously food products of various sizes and densities.

"This is a major technological thrust," says Larry A. Oberkfell, SureBeam's President and CEO. "This new system design gives SureBeam significant capability. We are now able to employ high-efficiency, cost- effective electron beam processing on differing products moving simultaneously side-by-side without any sacrifice in quality. This advancement has direct in-line application to ready-to-eat processors who want to process multiple products simultaneously, for example, an assortment of luncheon meats of differing weights or thicknesses."

Similar to a microwave oven, the SureBeam® system uses ordinary electricity as its energy source to pasteurize food after it has been processed and packaged. The patented SureBeam® technology eliminates in seconds the threat of harmful food-borne bacteria such as E. coli O157:H7, Listeria, Campylobacter and Salmonella without compromising texture, taste, or nutritional value.

"SureBeam is the only company currently processing food for the nationwide retail market that uses both electron beam and x-ray technology," says Oberkfell. "Any innovation that improves in-line agility directly benefits a processor's productivity, efficiency, and cost."

Currently, the FDA and USDA have approved SureBeam's® electronic pasteurization technology for use on raw meats, fruits and vegetables. In addition to raw meats, vegetables, and fruits, SureBeam has expanded its agreements with many of the nation's major ready-to-eat food companies in anticipation of the FDA and USDA's approval of the use of SureBeam's technology on precooked, ready-to-eat foods. According to the CDC, every year 76 million Americans get sick and over 5,000 people -- usually children and the elderly -- die from food-borne diseases. E. coli and salmonella, for example, are found in raw foods, such as hamburger, while listeria is found in precooked, ready-to-eat foods, such as hot dogs, deli meats, and soft cheese. Supported by our nation's most prominent health and medical organizations, SureBeam technology is specifically designed to help stop the spread of food borne diseases. SureBeam processed products are sold across the nation in thousands of supermarkets, as well as by home delivery, direct mail, and through food service.

SureBeam Corporation was created, built, and launched by The Titan Corporation (NYSE: TTN) in an initial public offering on March 16.

Headquartered in San Diego, California, SureBeam is a leading provider of electronic pasteurization systems and services for the food industry. SureBeam's technology significantly improves food safety, prolongs shelf life, and provides disinfestation that helps to protect the environment. The SureBeam® patented electronic pasteurization system is based on proven electron beam and x-ray technology that destroys harmful food-borne bacteria. This technology can also eliminate the need for toxic chemical fumigants used in pest control that may be harmful to the earth's ozone layer.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: The statements contained in this release, which are not historical facts, are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Examples of such forward-looking statements include the anticipated FDA/USDA approval of SureBeam's technology for ready-to-eat foods, use of SureBeam technology by the processors of such foods, and consumer acceptance. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in or implied by forward- looking statements. These risks and uncertainties include the risks associated with the Company's entry into new commercial food pasteurization markets that require the company to develop demand for its product, its ability to defend and maintain its patents, and other risks described in the Company's Securities and Exchange Commission filings.